FlyteHealth

What FlyteHealth does

FlyteHealth is a tech-enabled healthcare services company that delivers cardio-kidney-metabolic (CKM) care to self-insured employers, health plans, and individual patients, with a primary focus on obesity treatment. Founded in 2012 as Intellihealth by obesity medicine pioneers Dr. Louis Aronne and Dr. Katherine Saunders, the company rebranded to FlyteHealth in July 2024 and is headquartered in New Canaan, CT. Its core platform combines board-certified obesity medicine physicians, a multidisciplinary care team, and the patent-pending Flyte Intelligence AI engine, which drives an AI prescribing model and a patient-acuity prioritization model that direct more than 70% of patients to non-GLP-1 medications while reserving high-cost GLP-1s for highest-need cases. The product suite includes the FlyteHealth patient mobile app, comprehensive patient evaluation (labs, PHQ-8, SDOH), and connected eCKM programs built around the CDC's Diabetes Prevention Program framework, delivered via a five-pillar care model (scientific validation, expert medical care, personalized planning, behavioral support, AI-driven precision).

FlyteHealth operates a B2B enterprise subscription model, charging self-insured employers and health plans on a per-covered-life basis (approximately $1,800 per eligible member per year, with modeled savings of $2,006 per enrolled member per year). Go-to-market combines direct enterprise sales with broker/consultant partnerships (USI, Mercer, NFP, AON, WTW, Gallagher, Segal) and, more recently, ecosystem partnerships with SmithRx (PBM) and Eli Lilly's Employer Connect platform, the latter providing access to Zepbound at $449 per dose. Reported clinical outcomes include 13-16% average weight loss at 12 months, 86% GLP-1 adherence, 7.2% HbA1c reduction, and 9.4% blood glucose reduction; the State of Connecticut Health Plan partnership has enrolled 11,500+ members and generated $100 PMPM in medical savings and $29.7M in pharmacy cost avoidance in FY 2024-2025. The company maintains SOC 2 Type I, HITRUST, and HIPAA certifications and was selected for the CMS Health Tech Ecosystem in the Diabetes and Obesity category in June 2026, opening a Medicare Advantage go-to-market.

Name

FlyteHealth

Legal name

Intellihealth, Inc.

Website

https://flytehealth.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

FlyteHealth is a tech-enabled healthcare services company that delivers AI-driven cardio-kidney-metabolic and obesity care to self-insured employers, health plans, and Medicare Advantage buyers on a per-covered-life subscription model.

Ownership category

akta.pro rank

Product category

Obesity and Cardiometabolic Care Services

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Weight Loss Coaching (Non-Clinical) (HSADAFAB)

Keywords

• Obesity care services
• Cardiometabolic care platform
• GLP-1 medication management
• Employer health benefits
• Digital health programs

Headquarters

HQ city

New Canaan

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription/Per Covered Life: FlyteHealth generates revenue through subscription fees based on covered lives enrolled in their CKM care program. Pricing model is B2B, with employers and health plans paying per member per month or annual subscription.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

FlyteHealth provides an AI-driven early cardio-kidney-metabolic (eCKM) care platform that delivers comprehensive obesity and cardiometabolic treatment to populations covered by self-insured employers, health plans, and government plans. The offering combines patent-pending Flyte Intelligence prescribing algorithms with a multidisciplinary clinical care team (board-certified obesity medicine physicians, dietitians, and behavioral support) and a patient-facing mobile app, sold on a per-covered-life subscription basis with documented outcomes of 13–16% average weight loss at 12 months and measurable pharmacy cost avoidance.

Product overview

FlyteHealth is a unified cardio-kidney-metabolic care platform offering comprehensive early CKM (eCKM) care for employers and health plans. The core platform is powered by the patent-pending Flyte Intelligence AI platform, which drives medication protocols and personalized treatment plans. The product portfolio includes the FlyteHealth Patient App for patient engagement and telehealth, the Connected eCKM Programs spanning lifestyle support through clinical treatment, comprehensive patient evaluation (including PHQ-8 and SDOH assessments), and the Weight Matters educational podcast hosted by founding obesity medicine experts Dr. Louis Aronne and Dr. Katherine Saunders. The Five-Pillar Care Model integrates scientific validation, expert medical care, personalized planning, behavioral support, and AI-driven precision. FlyteHealth was rebranded from Intellihealth in July 2024.

Differentiator

Problem solved

Functional benefit

Brands

• Flyte Intelligence: Patent-pending AI-powered obesity treatment platform that drives medication protocols and care plans, enabling cost-effective treatment.
• Weight Matters

Products and services

• FlyteHealth Platform (Early CKM Care Platform) Comprehensive early cardio-kidney-metabolic (eCKM) care platform that helps self-insured employers, health plans, and government plans improve outcomes, reduce costs, and support healthier populations by addressing hypertension, hyperlipidemia, prediabetes, obesity, and other cardiometabolic risk factors. Delivered on a per-covered-life subscription to organizational buyers.
• Flyte Intelligence AI Platform Patent-pending AI platform that drives medication protocols and personalized care plans, enabling over 70% non-GLP-1 medication usage for cost savings while ensuring patients with the highest clinical need receive appropriate treatment intensity via its Acuity Model. Powers the FlyteHealth Platform offering.
• Connected Early Cardio-Kidney-Metabolic (eCKM) Programs Comprehensive care spanning lifestyle support to clinical treatment and long-term maintenance. The lifestyle program follows the CDC's Diabetes Prevention Program (DPP) framework and is offered independently or as part of the connected model to lower total cost of care.
• FlyteHealth Patient Mobile Application Mobile application providing patient access to the FlyteHealth care team, treatment plans, progress tracking, telehealth services, and secure messaging with clinical staff.

Quantifiable outcome

• 13-16% average weight loss at 12 months
• +6 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and flagship.

• SmithRxcoreChannel Partner/ Reseller/ Distributor · 9 June 2026FlyteHealth is part of SmithRx's best-in-class partner ecosystem for GLP-1 programs, helping employers deliver sustainable and clinically appropriate obesity and weight management coverage using manufacturer-approved pricing and transparent PBM model.
• Centers for Medicare & Medicaid Services (CMS)coreStrategic or Co-development Partner · 2 June 2026FlyteHealth selected for CMS Health Tech Ecosystem directory in the Diabetes and Obesity category, serving as a curated reference for Medicare Advantage organizations and CMS-affiliated health plans.
• Eli LillycoreStrategic or Co-development Partner · 5 March 2026FlyteHealth is a partner in Eli Lilly's Employer Connect platform, offering employers tailored obesity coverage options including access to Zepbound KwikPen at $449 per dose across all strengths.
• State of Connecticut Health PlanflagshipStrategic or Co-development Partner · 1 July 2023Multi-year partnership providing Comprehensive Obesity Care program to State of Connecticut health plan members and retirees. Program has enrolled over 11,500 members and generated significant cost savings.
• USIcoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• MercercoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• NFPcoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• AONcoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• WTWcoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• GallaghercoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions
• SegalcoreChannel Partner/ Reseller/ DistributorBenefits broker partner representing employer clients seeking obesity and CKM care solutions. Segal Group also conducted independent evaluation of Connecticut partnership results.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Ilant Health: Emerging employer- and health-plan-focused obesity care company combining clinical treatment with GLP-1 access. Comparable to FlyteHealth on obesity-only specialty, enterprise GTM, and payer-broker distribution; earlier stage with less proven clinical outcomes data.
• Mochi Health: Telehealth obesity medicine practice prescribing GLP-1s and providing physician-led care, with employer partnerships. Comparable to FlyteHealth on obesity-specialist-led virtual care and GLP-1 focus; smaller scale and earlier stage in enterprise channel development.

Direct peers

• Omada Health: Digital cardiometabolic care platform serving self-insured employers and health plans with programs spanning diabetes prevention, hypertension, and weight management. Closely comparable to FlyteHealth in buyer segment, B2B2C distribution model, and chronic-condition orientation; Omada is significantly larger and more broadly deployed across chronic conditions.
• Found: Telehealth obesity care platform with medication (including GLP-1s) and behavior change, primarily D2C with growing employer offerings. Comparable to FlyteHealth on obesity-focused, GLP-1-capable virtual care model; primarily consumer-acquired rather than employer-anchored.
• Form Health: Obesity medicine practice providing physician-supervised care including GLP-1 medications, sold via self-pay and employer partnerships. Comparable to FlyteHealth on board-certified obesity medicine physician leadership and intensive GLP-1-inclusive care; smaller scale and less enterprise-channel development.
• Virta Health: Telehealth platform providing physician-led obesity and type 2 diabetes reversal care to employers, health plans, and government payers. Highly comparable to FlyteHealth on care model (physician-supervised, app-enabled, GLP-1 capable), buyer segment (self-insured employers), and outcomes-driven value proposition; Virta is more diabetes-anchored and has raised substantial capital.
• Calibrate: Telehealth obesity treatment combining clinician care, GLP-1 prescribing, and behavior change; sells to employers and directly to consumers. Directly comparable to FlyteHealth on obesity-specific care model and GLP-1 stewardship; Calibrate's hybrid D2C + B2B model differs from FlyteHealth's enterprise-first GTM.
• Wondr Health: Digital weight management and metabolic health program sold primarily through self-insured employers and benefits brokers. Overlaps directly with FlyteHealth on employer GTM, broker distribution, and behavioral + clinical weight-loss approach; Wondr is more lifestyle-behavioral and less clinically intensive on GLP-1 management.
• Vida Health: Virtual chronic condition management platform covering diabetes, hypertension, weight, and mental health, sold to employers and health plans. Overlaps with FlyteHealth on cardiometabolic scope, employer channel, and AI-augmented coaching; Vida is broader across chronic conditions and less GLP-1-stewardship-focused.

Broad incumbents

• Noom: Established digital weight management platform with employer (Noom for Work) and direct-to-consumer offerings, now offering GLP-1-inclusive programs. Comparable to FlyteHealth on employer weight-management GTM and digital-first delivery; Noom is a broad incumbent with a much larger consumer brand and broader chronic-condition footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/FlyteHealth
• LinkedInlinkedin.com/company/flytehealth
• Xx.com/FlyteHealth

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FlyteHealth